Journal profile · PHARMACOLOGY & PHARMACY
Ars Pharmaceutica
ISSN 0004-2927 · eISSN 2340-9894 · Facultad de Farmacia, Universidad de Granada · Spain
Ars Pharmaceutica: CAS Zone 4 · Medicine (2025 upgraded edition); diamond open access (no APC); no APC; review about 10 weeks (community reports); 40 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Ars Pharmaceutica is published by Facultad de Farmacia, Universidad de Granada and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmaceutical Practices and Patient Outcomes, Drug Solubulity and Delivery Systems and Pharmaceutical studies and practices, together about 29% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmaceutical Practices and Patient OutcomesMedicine12.5%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics9%
- Pharmaceutical studies and practicesMedicine7.5%
- Medication Adherence and ComplianceMedicine6.5%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.7%
- Analytical Methods in PharmaceuticalsChemistry5.7%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics4.3%
- Health and Lifestyle StudiesHealth Professions3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 15OpenAlex ·
- i10-index
- 25OpenAlex ·
- 2-year mean citedness
- 0.36OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 95.88%LetPub ·
Volume
- Articles per year
- 38LetPub ·
Articles by year OpenAlex count · 330 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 28 | 28 | 0 |
| 2025 | 40 | 40 | 15 |
| 2024 | 35 | 35 | 22 |
| 2023 | 30 | 30 | 68 |
| 2022 | 29 | 29 | 59 |
| 2021 | 37 | 37 | 93 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-SA | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Facultad de Farmacia, Universidad de Granada
- Country or region
- Spain
- Language
- English, Spanish
- ISSN
- 0004-2927
- Electronic ISSN
- 2340-9894
- Official links
FAQ
Frequently asked questions about Ars Pharmaceutica
What CAS zone is Ars Pharmaceutica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Ars Pharmaceutica is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Ars Pharmaceutica?
Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Ars Pharmaceutica?
According to LetPub and DOAJ records, Ars Pharmaceutica is indexed in ESCI and DOAJ.
Is Ars Pharmaceutica open access, and what is the APC?
Ars Pharmaceutica is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .